ORIX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.1 USD | -1.13% |
|
+1.67% | +14.69% |
| 05-09 | Japanese shares rises on value stocks' appeal as rate hike looms | RE |
| 05-08 | Orix's Attributable Profit Up 19.2% in Fiscal 2024 | MT |
Strengths
- With a P/E ratio at 11.6 for the current year and 9.82 for next year, earnings multiples are highly attractive compared with competitors.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 3.1 times the sales for the current fiscal year, the company turns out to be overvalued.
- Revenue estimates are regularly revised downwards for the current and coming years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Consumer Lending
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +14.69% | 24.58B | - | ||
| -8.46% | 49.72B | C+ | ||
| -6.29% | 30.42B | C+ | ||
| +46.53% | 25.97B | - | - | |
| +17.60% | 18.03B | B | ||
| +0.72% | 12.9B | C+ | ||
| +13.70% | 10.35B | B- | ||
| +14.12% | 8.13B | C | ||
| -28.54% | 7.52B | - | ||
| +3.09% | 6.08B | C |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 8591 Stock
- IX Stock
- Ratings ORIX Corporation